{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:O43318",
      "entity_text" : "TAK1",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P0CE72",
      "entity_text" : "OCM",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Such OCM mediated TAK1 activation was considerably more apparent in 3bL8O17 cells, as evidenced by higher expression levels of p-TAK1 (Ser412) and p-IkappaBalpha (Ser32) when compared with those in 3bU2S8 cells, suggesting that TAK1 / NFkappaB activity was differentially regulated in metastatic cells and primary tumor cells upon OCM treatment.",
  "reading_complete" : "2020-08-02T14:09:38Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T14:07:17Z",
  "trigger" : "mediated",
  "evidence" : [ "OCM-mediated TAK1" ],
  "pmc_id" : "5835935",
  "score" : 0
}